Important: Therapy notes
- MHRA advice: Abacavir: risk of myocardial infarction - update from epidemiological studies (December 2014)
- Risk minimisation materials
Important: Formulation and dosage details
Formulation:
Tablets 300mg (specialist use only)
Important: Formulation and dosage details
Formulation:
Oral solution 100mg/5mL (specialist use only)
